Hair Loss Awareness Month

Advancing Hair Loss Solutions

As August marks Hair Loss Awareness Month, the Journal of Drugs in Dermatology (JDD) continues to champion evidence-based approaches for practicing dermatologists navigating this challenging field. Hair loss, from androgenetic alopecia to complex inflammatory conditions, remains a significant concern for millions, impacting patient quality of life profoundly. Understanding the latest diagnostics and emerging therapeutic options, such as novel topicals and JAK inhibitors, is essential for optimal patient outcomes. While new research is promising, keeping pace can be demanding. This month is a reminder to review contemporary studies, refine treatment protocols, and engage in vital patient education.

If you do not know where to start, click on the articles below to explore current insights and practical advancements in the field.

Review of Baricitinib in the Treatment of Alopecia Areata

Efficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia

Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice

Alopecia Areata: The Clinician and Patient Voice

Hair Loss in the Dermatology Office: An Update on Alopecia Areata

Blog write-up assisted by AI